These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4400283)

  • 1. Inhibition of NADPH-cytochrome c reductase by propyl gallate.
    Torrielli MV; Slater TF
    Biochem Pharmacol; 1971 Aug; 20(8):2027-32. PubMed ID: 4400283
    [No Abstract]   [Full Text] [Related]  

  • 2. The stimulatory effects of carbon tetrachloride on peroxidative reactions in rat liver fractions in vitro. Interaction sites in the endoplasmic reticulum.
    Slater TF; Sawyer BC
    Biochem J; 1971 Aug; 123(5):815-21. PubMed ID: 4399400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Demethylation of aminophenazone and codeine in human liver. An investigation of microsomal electron transport].
    Ackermann E
    Biochem Pharmacol; 1970 Jun; 19(6):1955-73. PubMed ID: 4398024
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of propyl gallate and other antioxidants on rat liver microsomal nicotinamide-adenine dinucleotide phosphate-linked cytochrome c reductase.
    Slater TF; Torrielli MV
    Biochem J; 1971 Feb; 121(3):40P. PubMed ID: 4399167
    [No Abstract]   [Full Text] [Related]  

  • 5. Microsomal electron transport reactions. I. Interaction of reduced triphosphopyridine nucleotide during the oxidative demethylation of aminopyrine and cytochrome b 5 reduction.
    Cohen BS; Estabrook RW
    Arch Biochem Biophys; 1971 Mar; 143(1):37-45. PubMed ID: 4397836
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection by glutathione and propyl gallate on the impaired in vitro amino acid incorporation into liver microsomal protein of CCL 4 -poisoned rats.
    Gravela E; Gabriel L; Ugazio G
    Biochem Pharmacol; 1971 Aug; 20(8):2065-70. PubMed ID: 5137962
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of microsomal drug-metabolizing enzymes from rat liver by various 4-hydroxycoumarin derivatives.
    Christensen F; Wissing F
    Biochem Pharmacol; 1972 Apr; 21(7):975-84. PubMed ID: 4114280
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of hepatic mixed function oxidase activity by propyl gallate.
    Yang CS; Strickhart FS
    Biochem Pharmacol; 1974 Nov; 23(22):3129-38. PubMed ID: 4155301
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of carbon tetrachloride and some antioxidants on the hydroxylation of tetralin by rat liver homogenate.
    Lin CC; Chen C
    Biochim Biophys Acta; 1969 Oct; 192(1):133-5. PubMed ID: 4390646
    [No Abstract]   [Full Text] [Related]  

  • 10. Species differences and drug metabolism.
    Flynn EJ; Lynch M; Zannoni VG
    Biochem Pharmacol; 1972 Oct; 21(19):2577-90. PubMed ID: 4145289
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of 2-hydroxyestradiol-17beta on NADPH-dependent electron transfer in rat liver microsomes in vitro (author's transl)].
    Wollenberg P; Scheulen M; Bolt HM; Kappus H; Remmer H
    Hoppe Seylers Z Physiol Chem; 1976 Mar; 357(3):351-7. PubMed ID: 8367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors involved in the inhibition of drug metabolism by (-)-emetine.
    Johnson RK; Mazel P; Donahue JD; Jondorf WR
    Biochem Pharmacol; 1971 May; 20(5):955-66. PubMed ID: 4400643
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for superoxide generation by NADPH-cytochrome c reductase of rat liver microsomes.
    Aust SD; Roerig DL; Pederson TC
    Biochem Biophys Res Commun; 1972 Jun; 47(5):1133-7. PubMed ID: 4402238
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the effects of halothane and CCl 4 on the hepatic drug metabolizing system.
    Davis DC; Schroeder DH; Gram TE; Reagan RL; Gillette JR
    J Pharmacol Exp Ther; 1971 Jun; 177(3):556-66. PubMed ID: 4398189
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possible participation of a free-radical lipid intermediate in the hydroxylation of polycyclic hydrocarbons].
    Dmitriev LF; Belevich NP; Davletshina LN; Ivanov II
    Biokhimiia; 1983 Dec; 48(12):2041-8. PubMed ID: 6322866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P-450 and its role in drug metabolism.
    Gillette JR; Davis DC; Sasame HA
    Annu Rev Pharmacol; 1972; 12():57-84. PubMed ID: 4114185
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunochemical studies on the role of reduced nicotinamide adenine dinucleotide phosphate-cytochrome c (P-450) reductase in drug oxidation.
    Glazer RI; Schenkman JB; Sartorelli AC
    Mol Pharmacol; 1971 Nov; 7(6):683-8. PubMed ID: 4402120
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects in vitro and in vivo of methylenedioxyphenyl compounds on oxidative phosphorylation in rat liver mitochondria.
    Nelson BD; Drake R; McDaniel O
    Biochem Pharmacol; 1971 Jun; 20(6):1139-49. PubMed ID: 4330203
    [No Abstract]   [Full Text] [Related]  

  • 19. Kinetic parameters of drug-metabolizing enzymes in Ca 2+ -sedimented microsomes from rat liver.
    Cinti DL; Moldeus P; Schenkman JB
    Biochem Pharmacol; 1972 Dec; 21(24):3249-56. PubMed ID: 4405367
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytochrome P-450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P-450-mediated reduction of oxygen and carbon tetrachloride.
    Persson JO; Terelius Y; Ingelman-Sundberg M
    Xenobiotica; 1990 Sep; 20(9):887-900. PubMed ID: 2122605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.